Elan Corp, plc (ADR) (NYSE:ELN)
CAPS Rating:
The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.
RSS Headlines
Fool UK
Recs
Company has excelled in the past with it's tenacious performance with most of its trials. This kind of tynasity canot go unrewarded for to long a period.